Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway

Tian-Kui Ma,1,* Li Xu,1,2,* Ling-Xu Lu,1,3,* Xu Cao,1 Xin Li,1 Lu-Lu Li,1 Xu Wang,4 Qiu-Ling Fan1 1Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 2Department of Clinical Laboratories, The First Hospital of China Med...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ma TK, Xu L, Lu LX, Cao X, Li X, Li LL, Wang X, Fan QL
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	ursolic acid diabetic nephropathy oxidative stress renal fibrosis arap1 at1r Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/5e30a8bc617b4a6e96e7773e9282d202
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5e30a8bc617b4a6e96e7773e9282d202
record_format	dspace
spelling	oai:doaj.org-article:5e30a8bc617b4a6e96e7773e9282d2022021-12-02T04:56:06ZUrsolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway1178-7007https://doaj.org/article/5e30a8bc617b4a6e96e7773e9282d2022019-12-01T00:00:00Zhttps://www.dovepress.com/ursolic-acid-treatment-alleviates-diabetic-kidney-injury-by-regulating-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Tian-Kui Ma,1,* Li Xu,1,2,* Ling-Xu Lu,1,3,* Xu Cao,1 Xin Li,1 Lu-Lu Li,1 Xu Wang,4 Qiu-Ling Fan1 1Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 2Department of Clinical Laboratories, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 3The First Respiratory Department, General Hospital of Fushun Mining Bureau, Fushun, Liaoning, People’s Republic of China; 4Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qiu-Ling Fan Email cmufql@163.comPurpose: This study aimed to investigate whether ursolic acid (UA) mitigates renal inflammation, oxidative stress and fibrosis by regulating the angiotensin II type 1 receptor-associated protein (ARAP1)/angiotensin II type 1 receptor (AT1R) signaling pathway and subsequently alleviating renal damage.Methods: db/db mice were divided randomly into a diabetic nephropathy (DN) group and a UA treatment group. Light microscopy and electron microscopy were used to observe pathological changes in renal tissues. Immunohistochemistry (IHC) was employed to examine changes in the expression of ARAP1, AT1R, 8-hydroxydeoxyguanosine (8-OHdG), NADPH oxidase 2 (NOX2), the extracellular matrix protein fibronectin (FN), IL-1β and IL-18 in renal tissues. Western blotting and RT-qPCR were used to detect the respective changes in the protein and mRNA levels of ARAP1, AT1R, NOX4, NOX2, transforming growth factor-β1 (TGF-β1), FN, collagen IV, IL-1β and IL-18 in renal tissues and mesangial cells. In addition, immunofluorescence staining was employed to examine changes in FN and NOX2 expression in mesangial cells.Results: UA treatment effectively reduced the body weights and blood glucose levels of db/db mice (p<0.05) as well as the urinary albumin/creatinine ratio (p<0.05). In addition, the renal tissue lesions and glomerulosclerosis index of the db/db mice were significantly improved after treatment (p<0.01). Histochemical analysis results showed significantly lower expression levels of ARAP1, AT1R, FN, NOX2, 8-OHdG, IL-1β and IL-18 in renal tissues in the UA treatment group than in the DN group. Western blotting and RT-qPCR data also revealed UA-induced decreases in the renal levels of the ARAP1, AT1, NOX4, NOX2, TGF-β1, FN, collagen IV, IL-1β and IL-18 proteins in vivo and/or in vitro (p<0.01). ARAP1 knockdown effectively reduced the expression of NOX2 and FN in vitro.Conclusion: UA alleviated renal damage in type 2 diabetic db/db mice by downregulating proteins in the ARAP1/AT1R signaling pathway to inhibit extracellular matrix accumulation, renal inflammation, fibrosis and oxidative stress.Keywords: ursolic acid, diabetic nephropathy, oxidative stress, renal fibrosis, ARAP1, AT1RMa TKXu LLu LXCao XLi XLi LLWang XFan QLDove Medical Pressarticleursolic aciddiabetic nephropathyoxidative stressrenal fibrosisarap1at1rSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 2597-2608 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	ursolic acid diabetic nephropathy oxidative stress renal fibrosis arap1 at1r Specialties of internal medicine RC581-951
spellingShingle	ursolic acid diabetic nephropathy oxidative stress renal fibrosis arap1 at1r Specialties of internal medicine RC581-951 Ma TK Xu L Lu LX Cao X Li X Li LL Wang X Fan QL Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
description	Tian-Kui Ma,1,* Li Xu,1,2,* Ling-Xu Lu,1,3,* Xu Cao,1 Xin Li,1 Lu-Lu Li,1 Xu Wang,4 Qiu-Ling Fan1 1Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 2Department of Clinical Laboratories, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 3The First Respiratory Department, General Hospital of Fushun Mining Bureau, Fushun, Liaoning, People’s Republic of China; 4Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qiu-Ling Fan Email cmufql@163.comPurpose: This study aimed to investigate whether ursolic acid (UA) mitigates renal inflammation, oxidative stress and fibrosis by regulating the angiotensin II type 1 receptor-associated protein (ARAP1)/angiotensin II type 1 receptor (AT1R) signaling pathway and subsequently alleviating renal damage.Methods: db/db mice were divided randomly into a diabetic nephropathy (DN) group and a UA treatment group. Light microscopy and electron microscopy were used to observe pathological changes in renal tissues. Immunohistochemistry (IHC) was employed to examine changes in the expression of ARAP1, AT1R, 8-hydroxydeoxyguanosine (8-OHdG), NADPH oxidase 2 (NOX2), the extracellular matrix protein fibronectin (FN), IL-1β and IL-18 in renal tissues. Western blotting and RT-qPCR were used to detect the respective changes in the protein and mRNA levels of ARAP1, AT1R, NOX4, NOX2, transforming growth factor-β1 (TGF-β1), FN, collagen IV, IL-1β and IL-18 in renal tissues and mesangial cells. In addition, immunofluorescence staining was employed to examine changes in FN and NOX2 expression in mesangial cells.Results: UA treatment effectively reduced the body weights and blood glucose levels of db/db mice (p<0.05) as well as the urinary albumin/creatinine ratio (p<0.05). In addition, the renal tissue lesions and glomerulosclerosis index of the db/db mice were significantly improved after treatment (p<0.01). Histochemical analysis results showed significantly lower expression levels of ARAP1, AT1R, FN, NOX2, 8-OHdG, IL-1β and IL-18 in renal tissues in the UA treatment group than in the DN group. Western blotting and RT-qPCR data also revealed UA-induced decreases in the renal levels of the ARAP1, AT1, NOX4, NOX2, TGF-β1, FN, collagen IV, IL-1β and IL-18 proteins in vivo and/or in vitro (p<0.01). ARAP1 knockdown effectively reduced the expression of NOX2 and FN in vitro.Conclusion: UA alleviated renal damage in type 2 diabetic db/db mice by downregulating proteins in the ARAP1/AT1R signaling pathway to inhibit extracellular matrix accumulation, renal inflammation, fibrosis and oxidative stress.Keywords: ursolic acid, diabetic nephropathy, oxidative stress, renal fibrosis, ARAP1, AT1R
format	article
author	Ma TK Xu L Lu LX Cao X Li X Li LL Wang X Fan QL
author_facet	Ma TK Xu L Lu LX Cao X Li X Li LL Wang X Fan QL
author_sort	Ma TK
title	Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
title_short	Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
title_full	Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
title_fullStr	Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
title_full_unstemmed	Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
title_sort	ursolic acid treatment alleviates diabetic kidney injury by regulating the arap1/at1r signaling pathway
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/5e30a8bc617b4a6e96e7773e9282d202
work_keys_str_mv	AT matk ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT xul ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT lulx ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT caox ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT lix ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT lill ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT wangx ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway AT fanql ursolicacidtreatmentalleviatesdiabetickidneyinjurybyregulatingthearap1at1rsignalingpathway
_version_	1718400952607703040

Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway

Ejemplares similares